A Generic Drug Face-Off Sends Mylan Soaring 19%
After the Food and Drug Administration surprisingly gave a green light to the company's Copaxone knockoff, shares in Mylan Inc. (NASDAQ: MYL) are surging 19.5% higher today at 11:30 a.m. EDT.
Teva Pharmaceutical (NYSE: TEVA) received bad news today when the FDA unexpectedly approved Mylan's long-lasting generic alternative to Copaxone 40 mg.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
€29.80
-0.670%
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
As a result the target price of 34 € shows a slightly positive potential of 14.09% compared to the current price of 29.8 € for Teva Pharmaceutical Industries Ltd ADR.
